Painful motion around the metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints is often precipitated by conditions such as arthritis, neuromuscular diseases, trauma, connective tissue disorder, and biomechanical instability, which can interfere with daily activities. This is generally addressed using conservative methods including physical therapy and nonsteroidal anti-inflammatory drugs (NSAIDs). Digit replacement is a surgical procedure mainly performed to relieve pain and restore function by replacing damaged joint surfaces with artificial implants. The major risk factors that contribute to digit replacement are osteoarthritis and rheumatoid arthritis resulting from old age.
Digit replacement is an intervention indicated for dysfunction of the finger joint due to trauma or arthritis. It is a substitute to arthrodesis when joint pain begins to interfere with daily activities and other medical management routes fail to provide relief. The procedure is complicated and there is a steep learning curve to competency as low procedure numbers prevent surgeons from getting enough hands-on experience. The goal of digit arthroplasty is to relieve pain, fix deformities and maintain the function and appearance of the fingers. Compared to other arthroplasties, the market share of digit replacement is paltry and therefore its addition to a company’s portfolio is normally a strategic business decision.
It is estimated that sales of digit replacement implants to be approximately US$65.5M across Globally in 2016. This market will grow at a CAGR of 5% over the forecast period, reaching sales of US$92.2M by 2023.
Both South American and the APAC digit replacement market is projected to grow at a CAGR of 6%, followed by North America, Europe and Middle East and Africa at 5.2%, 4% and 3.2% respectively. The US represented the largest portion of the market in 2016, holding almost 95% of the regional revenue, and is expected to maintain this dominance through the forecast period, followed by Brazil holding more than 72%.
The market for digit replacement is divided into two product categories: silicone and pyrolytic-based implants. The most popular finger implant is the silicone-based Swanson prosthesis, the gold standard upon which several silicone finger joint prostheses designs are based. Other players in this market include Integra LifeSciences, Stryker, Wright Medical, Zimmer Biomet, and Depuy Orthopedics.
The report "MediPoint: Digit Replacement - Global Analysis and Market Forecasts", focuses on the market outlook for digit replacement devices globally. The analysis identifies the key unmet needs in the digit replacement market, discusses the major drivers and barriers of adoption, and provides an in-depth understanding of physicians’ perceptions and the future outlook for this market by segment and geography.
Companies mentioned in this report: Integra LifeSciences, Stryker, Wright Medical, Zimmer Biomet, Depuy Orthopaedics.
*Note: This is an on-demand report and will be delivered within 3 working days (excluding weekends) of the purchase.
- Outlook of sales volume, pricing trends, revenue trends with 2016 as base year and forecasts until 2023, for digit replacement implants.
- Company share analysis in 2016, for digit replacement implants.
- Market insights and competitive assessment of the key players within the digit replacement market.
Reasons to buy
- Identify the unmet needs with the current generation of digit replacement implants and understand how emerging technologies will meet these unmet needs.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the digit replacement market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors.
2. Executive Summary
2.1. Key Metrics
2.2. Market Dynamics
2.3. Key Players
2.4. Future Outlook
2.5. What Do Physicians Think?
3.2. Related Reports
3.3. Upcoming Related Reports
4. Market Outlook
4.1. Procedure Trends
4.2. Pricing Trends
4.3. Revenue Trends
4.4. Company Share Analysis
5. Market Insights
5.1. North America
5.2.1. Denmark, Finland, Norway, and Sweden
5.2.2. Belgium, France, and Netherlands
5.2.3. Germany and Switzerland
5.2.4. UK and Ireland
5.2.5. Italy, Portugal, and Spain
5.2.6. Austria, Czech Republic, Hungary, and Poland
5.2.7. Russia, Turkey, and Greece
5.3.1. Australia & New Zealand
5.3.2. China & Taiwan
5.3.5. South Korea
5.4. South America
5.4.2. Argentina & Chile
5.5. Middle East and Africa
5.5.2. South Africa
5.5.3. Egypt, Saudi Arabia, and UAE
6. Competitive Assessment
6.2. Integra LifeSciences
6.2.1. Portfolio Assessment
6.2.2. Deal Analysis
6.2.3. Competitive Positioning
6.3.1. Portfolio Assessment
6.3.2. Deal Analysis
6.3.3. Competitive Positioning
6.4. Wright Medical
6.4.1. Portfolio Assessment
6.4.2. Deal Analysis
6.4.3. Competitive Positioning
6.5. Zimmer Biomet
6.5.1. Portfolio Assessment
6.5.2. Deal Analysis
6.5.3. Competitive Positioning
6.6. Depuy Orthopaedics
6.6.1. Portfolio Assessment
6.6.2. Deal Analysis
6.6.3. Competitive Positioning
6.7. Other Players
7.3.3. Secondary Research
7.3.4. Forecasting Methodology
7.3.5. Primary Research Summary
7.4. About the Authors
7.4.2. Global Head of Medical Devices
7.5. About MediPoint
7.6. About the Publisher
7.7. Contact Us
1.1 List of Tables
Table 1: Key Metrics in the North American Markets
Table 2: Key Metrics in the European Markets
Table 3: Key Metrics in the APAC Markets
Table 4: Key Metrics in the South America Markets
Table 5: Key Metrics in the Middle East and Africa Markets
Table 6: North America Procedure Volume Forecast, 2014-
Table 7: Europe Procedure Volume Forecast, 2014-
Table 8: APAC Procedure Volume Forecast, 2014-
Table 9: South America Procedure Volume Forecast, 2014-
Table 10: Middle East and Africa Procedure Volume Forecast, 2014-
Table 11: North America Average Selling Price Forecast, 2014-
Table 12: Europe Average Selling Price Forecast, 2014-
Table 13: APAC Average Selling Price Forecast, 2014-
Table 14: South America Average Selling Price Forecast, 2014-
Table 15: Middle East and Africa Average Selling Price Forecast, 2014-
Table 16: North America Sales Forecast ($M), 2014-
Table 17: Europe Sales Forecast ($M), 2014-
Table 18: APAC Sales Forecast ($M), 2014-
Table 19: South America Sales Forecast ($M), 2014-
Table 20: Middle East and Africa Sales Forecast ($M), 2014-
Table 21: North America Company Share Analysis,
Table 22: Europe Company Share Analysis,
Table 23: APAC Company Share Analysis,
Table 24: South America Company Share Analysis,
Table 25: Middle East and Africa Company Share Analysis,
Table 26: Integra LifeSciences - Key Marketed Products Assessment
Table 27: Stryker - Key Marketed Products Assessment
Table 28: Wright Medical - Key Marketed Products Assessment
Table 29: Zimmer Biomet Medical - Key Marketed Products Assessment
Table 30: Zimmer Biomet Medical - Key Marketed Products Assessment
Table 31: Summary of Other Players in the Market,
1.2 List of Figures
Figure 1: North America Sales for Digit Replacement, by Country, 2016 and
Figure 2: Europe Sales for Digit Replacement by Country, 2016 and
Figure 3: Middle East and Africa Sales for Digit Replacement by Country, 2016 and